Insights On Upstream Manufacturing

  1. Supply Chain Efficiency And Sourcing In Gene Therapy 11/4/2025

    An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

  2. Inside Bioprocessing: Microbial Media 11/4/2025

    Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.

  3. Basic Cell Culture Education Series: CHO Media 11/4/2025

    This Knowledge Culture Basic Education Series on CHO media will explore CHO cells: their lineage, historical culture media, and process improvements. We will dive into how to optimize cell culture performance for superior outcomes.

  4. Inside Bioprocessing: Continuous Perfusion 11/4/2025

    Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.

  5. Cell Culture Media Manufacturing, Paisley, Scotland 11/4/2025

    Learn more about our cell culture media manufacturing global network, including details of the Paisley, Scotland site's capacity expansion supporting the bioprocessing industry's rapidly growing needs.

  6. Cell Culture Media Manufacturing, Grand Island, NY 11/4/2025

    Learn more about our cell culture media manufacturing global network, including details of the Grand Island, New York sites capacity expansion supporting the bioprocessing industrys rapidly growing needs.

  7. Scale-Up Of A Transient rAAV Production Process 11/3/2025

    Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.

  8. Scale-Up Of An Adherent rAAV Production Process 11/3/2025

    Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.

  9. Exosome Production From hMSC Using A Fixed-Bed Bioreactor 11/3/2025

    Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

  10. Expansion Of Human Bone Marrow-Derived MSCs 11/3/2025

    Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.